| Fibrinogen-like protein 1 is a major immune inhibitory ligand of LAG-3 J Wang, MF Sanmamed, I Datar, TT Su, L Ji, J Sun, L Chen, Y Chen, ... Cell 176 (1), 334-347. e12, 2019 | 667 | 2019 |
| Siglec-15 as an immune suppressor and potential target for normalization cancer immunotherapy J Wang, J Sun, LN Liu, DB Flies, X Nie, M Toki, J Zhang, C Song, M Zarr, ... Nature medicine 25 (4), 656-666, 2019 | 504 | 2019 |
| Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies. MI Chester C, Sanmamed MF, Wang J Blood 2017 (06), 741041, 2017 | 404* | 2017 |
| Changes in serum interleukin-8 (IL-8) levels reflect and predict response to anti-PD-1 treatment in melanoma and non-small-cell lung cancer patients MF Sanmamed, JL Perez-Gracia, KA Schalper, JP Fusco, A Gonzalez, ... Annals of Oncology 28 (8), 1988-1995, 2017 | 393 | 2017 |
| Expression analysis and significance of PD-1, LAG-3, and TIM-3 in human non–small cell lung cancer using spatially resolved and multiparametric single-cell analysis I Datar, MF Sanmamed, J Wang, BS Henick, J Choi, T Badri, W Dong, ... Clinical Cancer Research 25 (15), 4663-4673, 2019 | 256 | 2019 |
| IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy T Zhou, W Damsky, OE Weizman, MK McGeary, KP Hartmann, CE Rosen, ... Nature 583 (7817), 609-614, 2020 | 220 | 2020 |
| Platelets contribute to disease severity in COVID‐19 TJ Barrett, S Bilaloglu, M Cornwell, HM Burgess, VW Virginio, K Drenkova, ... Journal of Thrombosis and Haemostasis 19 (12), 3139-3153, 2021 | 149 | 2021 |
| S100A4 promotes liver fibrosis via activation of hepatic stellate cells L Chen, J Li, J Zhang, C Dai, X Liu, J Wang, Z Gao, H Guo, R Wang, S Lu, ... Journal of Hepatology 62 (1), 156-164, 2015 | 140 | 2015 |
| SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2 Q Lu, J Liu, S Zhao, MFG Castro, M Laurent-Rolle, J Dong, X Ran, ... Immunity 54 (6), 1304-1319. e9, 2021 | 131 | 2021 |
| Deep learning-based prediction of the T cell receptor–antigen binding specificity T Lu, Z Zhang, J Zhu, Y Wang, P Jiang, X Xiao, C Bernatchez, ... Nature machine intelligence 3 (10), 864-875, 2021 | 106 | 2021 |
| PD-1, PD-L1(B7-H1) and Tumor-Site Immune Modulation Therapy: The Historical Perspective J Wang, R Yuan, W Song, J Sun, D Liu, Z Li Journal of Hematology and Oncology 10 (34), 2017 | 105 | 2017 |
| A Burned-Out CD8+ T-cell Subset Expands in the Tumor Microenvironment and Curbs Cancer Immunotherapy MF Sanmamed, X Nie, SS Desai, F Villaroel-Espindola, T Badri, D Zhao, ... Cancer discovery 11 (7), 1700-1715, 2021 | 95 | 2021 |
| Siglec-15 as an emerging target for next-generation cancer immunotherapy J Sun, Q Lu, MF Sanmamed, J Wang Clinical Cancer Research 27 (3), 680-688, 2021 | 91 | 2021 |
| Immune asynchrony in COVID-19 pathogenesis and potential immunotherapies T Zhou, TT Su, T Mudianto, J Wang Journal of Experimental Medicine 217 (10), e20200674, 2020 | 70 | 2020 |
| CD137-mediated pathogenesis from chronic hepatitis to hepatocellular carcinoma in hepatitis B virus-transgenic mice J Wang, W Zhao, L Cheng, M Guo, D Li, X Li, Y Tan, S Ma, S Li, Y Yang, ... The Journal of Immunology 185 (12), 7654-7662, 2010 | 69 | 2010 |
| Interleukin-6 induces Gr-1+ CD11b+ myeloid cells to suppress CD8+ T cell-mediated liver injury in mice L Cheng, J Wang, X Li, Q Xing, P Du, L Su, S Wang PloS one 6 (3), e17631, 2011 | 66 | 2011 |
| LSECtin on tumor-associated macrophages enhances breast cancer stemness via interaction with its receptor BTN3A3 D Liu, Q Lu, X Wang, J Wang, N Lu, Z Jiang, X Hao, J Li, J Liu, P Cao, ... Cell research 29 (5), 365-378, 2019 | 48 | 2019 |
| Neuron-specific SALM5 limits inflammation in the CNS via its interaction with HVEM Y Zhu, S Yao, MM Augustine, H Xu, J Wang, J Sun, M Broadwater, W Ruff, ... Science advances 2 (4), e1500637, 2016 | 44 | 2016 |
| Mechanical activation of spike fosters SARS-CoV-2 viral infection W Hu, Y Zhang, P Fei, T Zhang, D Yao, Y Gao, J Liu, H Chen, Q Lu, ... Cell Research 31 (10), 1047-1060, 2021 | 36 | 2021 |
| Pik3ip1 is a negative immune regulator that inhibits antitumor T-cell immunity Y Chen, J Wang, X Wang, X Li, J Song, J Fang, X Liu, T Liu, D Wang, Q Li, ... Clinical Cancer Research 25 (20), 6180-6194, 2019 | 31 | 2019 |
Lieping ChenYale University School of MedicineVerified email at yale.edu
